Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Palantir

Palantir Stock Is Treading Water - Good for Short-Put Trades That Yield 2.0% in 3 Weeks

Palantir stock has been trading in the mid-$20s since posting its Q4 earnings on Feb. 5. Its put option premiums are high and yield up to 2.0% for 3 weeks expiration, ideal for existing shareholders.

Barchart

1 Outstanding Growth Stock to Buy Under $30

This AI software stock's strategic partnerships are paving the way for a brighter future. Up 36% YTD, how high can this underrated growth stock climb?

Barchart

Here's How High Wall Street Thinks Palantir Stock Can Rise

Palantir stock has more than tripled in the last 12 months, making it quite expensive at the current valuation. Can the AI tech stock continue to surge in 2024?

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Bubble? These 2 AI Stocks Have Exceeded Goldman Sachs' Price Targets

Amid concerns over a potential bubble in the AI industry, some of these hot stocks have already surpassed Goldman's price targets. Are these AI stocks overbought - and how much upside is the rest of Wall Street expecting? Here's a closer look.

Barchart

Shorting Palantir's Out-of-the-Money Puts Makes Sense Here for a 2.26% Yield in 3 Weeks

Palantir stock is worth considerably more than its present price given its huge free cash flow and management's forecast. Shorting a 5% OTM put for March 22 expiry produces a 2.26% yield.

Barchart

Rightwing mega-donors drift back to Trump as election rematch looms

Former president is enjoying some success in courting sceptical funders but some, such as Peter Thiel, have spurned his advances

The Guardian - US

Up 167% in 2023, Can This AI Stock Keep Rising in 2024?

The company's strong AI-driven data analytics and software solutions continue to drive its fundamentals, with the stock up more than 42% YTD. How much higher can it go?

Barchart

Read news from The Economist, FT, and more,
with one subscription

'Mil-Tech Valley': How Ukraine is turning into a living AI war lab — with the help of a global armada of tech companies

Ukraine is evolving into the world's tech R&D lab, with support from Microsoft, Amazon, and Google.

TechRadar

Stock Market Today: Higher Close for Stocks, Palantir Soars on AI Optimism

While the main indexes made modest moves Tuesday, Palantir Technologies soared 30% after earnings.

Kiplinger

Palantir Predicts Strong 2024 Profit, Shares Soar on AI Demand

Palantir's strong forecast for 2024 profit due to increased demand for their AI technology leads to a surge in share prices. Learn more here.

Top News

Bearish Analyst Expects Palantir Technologies Stock to Sink 26%

Palantir stock has more than doubled over the past year, but the latest analyst note from Deutsche Bank calls for the stock to enter its own personal bear market over the next year. Here's a closer look at Wall Street's latest pessimistic take on PLTR.

Barchart

Palantir Is Down, But Its FCF Could Make It Worth 21% More at $20 Per Share

Palantir Technologies stock is off its peak of $21.26 per share. But its powerful free cash flow could push PLTR stock up over 21% to that peak. One way investors can play this is to short OTM puts.

Barchart

Down 21%, Is Palantir Stock a Buy Right Now?

Palantir stock has pulled back sharply from its post-earnings peak - but the shares still trade at a premium, and Wall Street analysts think there may be more downside in store for this AI stock over the short term.

Barchart

PLTR vs. META: Which AI Growth Stock is Wall Street's Favorite for 2024?

While both Palantir and Meta Platforms are positioned for a stronger AI-fueled future in 2024, Wall Street is bullish on one stock's long-term prospects - and cautiously optimistic on the other.

Barchart

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

Palantir (PLTR) and UiPath (PATH) - Buy, Hold, or Sell in 2024?

The software industry has been put under strain as a result of macroeconomic concerns. However, the future of the industry looks optimistic. Therefore, let us analyze whether software stocks Palantir Technologies (PLTR) and UiPath (PATH) are Buy, Hold, or Sell now.

The Guardian - UK

My plan to topple the Tory dark lords in 2024

We need a fellowship of socially conscious heroes to fight the Conservatives and NHS data-grabbing firms and save our democracy

The National (Scotland)

Good Law Project: US tech giant is offering to pay influencers to 'attack' us

THE Good Law Project has claimed a US tech giant has hired a PR firm to pay influencers to attack it on social media amid its investigation into an…

The National (Scotland)

Health workers blockade office of tech giant with NHS contract over ties to Israel

Demonstrators blockaded the central London office of US tech giant Palantir after it was awarded a contract worth hundreds of millions of pounds for…

Get all your
news in one place.

100’s of premium titles.
One news app.

Evening Standard

Protesters blockade London office of tech giant with NHS contract over ties to Israel

Dozens of pro-Palestine demonstrators blocked the entrance to Palantir in central London

Barchart

Is Palantir Stock Really Headed to Just $5 Per Share?

Palantir stock has more than doubled in 2023, but lost 9% to start the week after a bearish analyst note. Are concerns about the AI software company's contract pipeline overdone, or is major downside ahead for the stock in 2024?

Barchart

Palantir Still Has Room to Rise, and Could Be Worth Up to 20% More

Palantir stock is still undervalued given its powerful free cash flow. With a 27% FCF margin and an FCF yield of 1.5% PLTR stock is worth 20% more. Shorting OTM puts is a good income play.

The Guardian - UK

You may balk at giving your health data to Palantir but it could save your life

The NHS’s deal with the US tech company raises privacy concerns but a unified database could be a medical gamechanger

The Conversation

Palantir: privacy fears over handing NHS data to US defence provider show how lack of trust is holding back much-needed reform

Controversial US tech company Palantir has been awarded a £330 million contract to create a new system for sharing data – including patients’ medical details – within the NHS in England.

The National (Scotland)

SNP MP grills Rishi Sunak over US tech firm's NHS contract

SNP MP Deidre Brock grilled Rishi Sunak at PMQs on Wednesday over NHS England’s awarding of an IT contract to US tech firm Palantir.

The Guardian - UK

The Guardian view on the NHS and Palantir: the case for this data deal looks weak

Editorial: Hiring a controversial US technology company to build an NHS data platform risks undermining public trust

1 … 37 38 39 40

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations